Back to search

Belgium· BE-AMP-SAM401624-00

Dehydrobenzperidol 0.5 mg/ml

A droperidol product containing droperidol, registered in Belgium by Substipharm. The same ATC class is registered in 11 of our 19 countries.

ATC N05AD08

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedDehydrobenzperidol 0.5 mg/mlATCN05AD08REGISTER NO.BE-AMP-SAM401624-00PACKS LISTED1CHECKEDSeptember 26, 2026

Where it is registered

Droperidol is registered in 11 of 19 countries.

Countries holding a registration under ATC N05AD08 (droperidol), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 5 of them publish a price we can compare per daily dose

Droperidol · ATC N05AD08

11 / 19 countries

  • Belgiumprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Droperidol
Manufacturer
Substipharm
Country
Belgium (BE)
ATC code
N05AD08
ATC class
Droperidol
Defined daily dose
2.5 mg, P
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 1

  • be_apb
    2989044

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

273 interactions on record for droperidol.

Graded by severity as the source publishes them — 154 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Droperidol · interactions on record

273 records

  • 154 severe
  • 88 moderate
  • 2 minor
  • 27 info

Most severe, free to view

  • PapaverineA03AD01severe
  • MetoclopramideA03FA01severe
  • CisaprideA03FA02severe
  • OndansetronA04AA01severe

2 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Droperidol in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All droperidol products

Authorised across Europe · EMA

The same active substance is authorised in 19 EEA countries. Names it is sold under:

  • Austria · Droperidol Aguettant, Droperidol Hikma
  • Germany · Droperidol Aguettant, Droperidol Carinopharm
  • Denmark · Dehydrobenzperidol Substipharm, Droperidol Aguettant
  • Spain · Droperidol Hikma, Droperidol Kalceks
  • Finland · Dehydrobenzperidol Substipharm, Droperidol Aguettant
  • France · Droleptan, Droperidol Aguettant
  • United Kingdom (Northern Ireland) · Droperidol Hikma Farmacêutica (Portugal), Droperidol Panpharma
  • Greece · Xomolix
  • Hungary · Droperidol Kalceks
  • Ireland · Droperidol Aguettant, Droperidol Laboratoire Aguettant
  • Iceland · Dridol, Droperidol Aguettant
  • Italy · Droperidol Kalceks, Droperidolo Aguettant
  • Luxembourg · Dehydrobenzperidol Substiparm, Dehydrobenzperidol Substipharm
  • Latvia · Droperidol Kalceks
  • Netherlands · Dehydrobenzperidol Iv Substipharm, Dehydrobenzperidol Substipharm
  • Norway · Dridol, Droperidol Aguettant
  • Portugal · Droperidol Aguettant, Droperidol Hikma
  • Romania · Droperidol Aguettant
  • Sweden · Dridol, Droperidol Aguettant

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/9d9b03a3-5260-429d-99b9-055db7269bb2
GET /v1/drugs/9d9b03a3-5260-429d-99b9-055db7269bb2?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for injection",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Dehydrobenzperidol 0.5 mg/ml",
  "name_fr": "Dehydrobenzperidol 0.5 mg/ml",
  "name_nl": "Dehydrobenzperidol 0.5 mg/ml",
  "amp_code": "SAM401624-00",
  "strengths": [
    "1.2500",
    "1.2500"
  ],
  "pack_count": 1,
  "substances": [
    "Droperidol"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Droperidol",
  "authorisation_numbers": [
    "BE401624"
  ]
}

See everything about droperidol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.